-
Cigna 'Top Pick for 2024': Analysts Change Ratings, Forecasts Following 2024 Guidance
Monday, February 5, 2024 - 1:39pm | 525Cigna Group (NYSE: CI) shares were rising in early trading on Monday after the company reported its fourth-quarter results. The results came amid an exciting earnings season. Here are some key analyst takeaways from the release. Cantor Fitzgerald On Cigna Analyst Sarah James upgraded the rating...
-
HCA Healthcare Price Estimates Raised On Strong Performance And Optimistic Outlook
Monday, April 24, 2023 - 11:16am | 561Shares of HCA Healthcare Inc (NYSE: HCA) continued to climb in early trading on Monday, after smashing earnings expectations and getting price targets bumped by analysts. Here are some key takeaways from additional analysts. Oppenheimer On HCA Healthcare Analyst Michael Wiederhorn maintained an...
-
3 Analysts Provide Takeaways From Walgreens' Upbeat Results
Friday, October 14, 2022 - 10:52am | 472Walgreens Boots Alliance Inc. (NASDAQ: WBA) swung to a loss in the third quarter but managed to beat Street expectations. The Deerfield, Illinois-based company reported that its sales had declined by 5.3% year-over-year to $32.4 billion and adjusted earnings of 80 cents per share, with both figures...
-
Why Walgreens Could Be Valued At $71/Share In A Leveraged Buyout
Tuesday, November 19, 2019 - 4:00pm | 523Mizuho raised the potential takeout range in a possible leveraged buyout for Walgreens Boots Alliance Inc (NASDAQ: WBA) to as high as $71 a share, but said something closer to $67 is more likely. The Analyst Mizuho analyst Ann Hynes raised the potential takeout range to $64-$71 per share, up from...
-
Mizuho Starts Bullish Coverage On Health Insurance Stocks
Friday, October 18, 2019 - 11:58am | 601Mizuho recommended buying three health insurer stocks as it initiated coverage of the sector Thursday. The Analyst Mizuho's Ann Hynes initiated coverage of Humana Inc. (NYSE: HUM) with a Buy rating and $316 price target. Hynes started Cigna Corp. (NYSE: CI) with a Buy and...
-
Analysts React To The Walgreens Q2 Earnings Miss
Wednesday, April 3, 2019 - 12:32pm | 820Walgreens Boots Alliance Inc (NASDAQ: WBA) on Tuesday reported fiscal second-quarter results that fell short of expectations in what management described as the "most difficult" quarter since late 2014. Here is a summary of how some of the Street's top analysts reacted to the print....
-
Analysts React To Diplomat Pharmacy's Q4 Earnings, Concerning Guidance
Monday, March 18, 2019 - 3:18pm | 530Diplomat Pharmacy Inc (NYSE: DPLO) on Friday reported its previously delayed fourth-quarter earnings miss and concerning guidance, which sent the stock tumbling nearly 14 percent. The Analysts Mizuho Securities' Ann Hynes maintains a Neutral rating on Diplomat Pharmacy with a price target...
-
Analyst: Don't Buy The Weakness In Acadia Healthcare
Monday, October 30, 2017 - 11:45am | 384Investors looking to buy shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) after a 25-percent decline in reaction to a disappointing earnings report may want to reconsider, according to analysts at Mizuho Securities. The firm's Ann Hynes downgraded Acadia's stock rating from Buy to Neutral...
-
What To Make Of The Rumored CVS Bid For Aetna
Friday, October 27, 2017 - 12:43pm | 455The big news on Wall Street Thursday afternoon was the potential $66 billion buyout of Aetna Inc (NYSE: AET) by CVS Health Corp (NYSE: CVS). Analysts are looking at the potential deal in terms of how traders should play the two stocks involved. Aetna stock jumped 11.5 percent following the news of...
-
Mizuho Analysts Call McKesson's UDG Buyout 'Nice'
Monday, September 21, 2015 - 2:05pm | 433In a recent report, Mizuho analysts qualify McKesson Corporation (NYSE: MCK)’s purchase of the pharmaceutical distribution division of UDG Healthcare as a “Nice Opportunistic Use of Cash.” The experts rate the stock a Buy, setting a price target of $275.00. Shares of...
-
Express Scripts' CEO Swap: What Wall Street Thinks
Thursday, September 10, 2015 - 3:24pm | 483Express Scripts Holding Company (NASDAQ: ESRX) announced that George Paz will retire as CEO mid-next year and will be replaced by Tim Wentworth. Shares of Express Scripts were relatively flat heading into Thursday's afternoon trading session. Analysts at Leerink and Mizuho agree the CEO transition...
-
Mizuho 'Struggles To Find Reasons' To Maintain Walgreen At Buy, Downgrades Shares To Neutral
Tuesday, December 9, 2014 - 12:23pm | 199Ann Hynes of Mizuho downgraded shares of Walgreen (NYSE: WAG) on Tuesday from Buy to Neutral with a price target lowered from $83 to $72, noting an unfavorable risk to reward profile over the next year. Walgreen released an updated proxy on November 24 providing earnings per share and EBITDA...
-
Mizuho Securities USA Sees Solid Underlying Business Trends For CVS Caremark
Monday, May 5, 2014 - 8:15am | 121In a report published Monday, Mizuho Securities USA analyst Ann Hynes reiterated a Buy rating and $81.00 price target on CVS Caremark (NYSE: CVS). In the report, Mizuho Securities USA noted, “We reiterate our Buy rating and $81 price target after a solid 1Q. Upside in the PBM helped offset...